These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Protein Kinase R Restricts the Intracellular Survival of Smyth R; Berton S; Rajabalee N; Chan T; Sun J Front Microbiol; 2020; 11():613963. PubMed ID: 33552025 [TBL] [Abstract][Full Text] [Related]
24. Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy. Gupta A; Sharma D; Meena J; Pandya S; Sachan M; Kumar S; Singh K; Mitra K; Sharma S; Panda AK; Gupta P; Gupta UD; Misra A Pharm Res; 2016 Aug; 33(8):1899-912. PubMed ID: 27095353 [TBL] [Abstract][Full Text] [Related]
25. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin. Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238 [TBL] [Abstract][Full Text] [Related]
26. Potential and development of inhaled RNAi therapeutics for the treatment of pulmonary tuberculosis. Man DK; Chow MY; Casettari L; Gonzalez-Juarrero M; Lam JK Adv Drug Deliv Rev; 2016 Jul; 102():21-32. PubMed ID: 27108702 [TBL] [Abstract][Full Text] [Related]
27. Opportunities and Challenges for Host-Directed Therapies in Tuberculosis. Sachan M; Srivastava A; Ranjan R; Gupta A; Pandya S; Misra A Curr Pharm Des; 2016; 22(17):2599-604. PubMed ID: 26818871 [TBL] [Abstract][Full Text] [Related]
28. Extracellular matrix-inspired inhalable aerogels for rapid clearance of pulmonary tuberculosis. Simonson AW; Umstead TM; Lawanprasert A; Klein B; Almarzooqi S; Halstead ES; Medina SH Biomaterials; 2021 Jun; 273():120848. PubMed ID: 33915409 [TBL] [Abstract][Full Text] [Related]
29. Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages. Guedj AS; Kell AJ; Barnes M; Stals S; Gonçalves D; Girard D; Lavigne C Int J Nanomedicine; 2015; 10():5965-79. PubMed ID: 26445538 [TBL] [Abstract][Full Text] [Related]
30. Inhalable particles containing rapamycin for induction of autophagy in macrophages infected with Mycobacterium tuberculosis. Gupta A; Pant G; Mitra K; Madan J; Chourasia MK; Misra A Mol Pharm; 2014 Apr; 11(4):1201-7. PubMed ID: 24533458 [TBL] [Abstract][Full Text] [Related]
31. Bazedoxifene Suppresses Intracellular Mycobacterium tuberculosis Growth by Enhancing Autophagy. Ouyang Q; Zhang K; Lin D; Feng CG; Cai Y; Chen X mSphere; 2020 Apr; 5(2):. PubMed ID: 32269154 [TBL] [Abstract][Full Text] [Related]
32. Comparative transcriptomic analysis of THP-1-derived macrophages infected with Mycobacterium tuberculosis H37Rv, H37Ra and BCG. Pu W; Zhao C; Wazir J; Su Z; Niu M; Song S; Wei L; Li L; Zhang X; Shi X; Wang H J Cell Mol Med; 2021 Nov; 25(22):10504-10520. PubMed ID: 34632719 [TBL] [Abstract][Full Text] [Related]
33. Inhalable microparticles containing nitric oxide donors: saying NO to intracellular Mycobacterium tuberculosis. Verma RK; Singh AK; Mohan M; Agrawal AK; Verma PR; Gupta A; Misra A Mol Pharm; 2012 Nov; 9(11):3183-9. PubMed ID: 22978290 [TBL] [Abstract][Full Text] [Related]
34. Functionalization of PLGA Nanoparticles with 1,3-β-glucan Enhances the Intracellular Pharmacokinetics of Rifampicin in Macrophages. Tukulula M; Gouveia L; Paixao P; Hayeshi R; Naicker B; Dube A Pharm Res; 2018 Mar; 35(6):111. PubMed ID: 29600438 [TBL] [Abstract][Full Text] [Related]
35. Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M.tuberculosis killing efficiency. Pi J; Shen L; Shen H; Yang E; Wang W; Wang R; Huang D; Lee BS; Hu C; Chen C; Jin H; Cai J; Zeng G; Chen ZW Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109777. PubMed ID: 31349400 [TBL] [Abstract][Full Text] [Related]
36. Comparison of Vibrating Mesh, Jet, and Breath-Enhanced Nebulizers During Mechanical Ventilation. Ashraf S; McPeck M; Cuccia AD; Smaldone GC Respir Care; 2020 Oct; 65(10):1419-1426. PubMed ID: 32694180 [TBL] [Abstract][Full Text] [Related]
37. Antimycobacterial activity of acetone extract and isolated metabolites from folklore medicinal lichen Usnea laevis Nyl. against drug-sensitive and multidrug-resistant tuberculosis strains. Tatipamula VB; Annam SSP J Ethnopharmacol; 2022 Jan; 282():114641. PubMed ID: 34536516 [TBL] [Abstract][Full Text] [Related]
38. Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles. Varshosaz J; Taymouri S; Hamishehkar H; Vatankhah R; Yaghubi S Res Pharm Sci; 2017 Jun; 12(3):222-232. PubMed ID: 28626480 [TBL] [Abstract][Full Text] [Related]
39. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review. Kiran D; Podell BK; Chambers M; Basaraba RJ Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950 [TBL] [Abstract][Full Text] [Related]
40. Potential Active Targeting of Gatifloxacin to Macrophages by Means of Surface-Modified PLGA Microparticles Destined to Treat Tuberculosis. Marcianes P; Negro S; Barcia E; Montejo C; Fernández-Carballido A AAPS PharmSciTech; 2019 Dec; 21(1):15. PubMed ID: 31807908 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]